According to a study recently conducted by a cancer research laboratory in the Netherlands, the latest new vaccines to prevent and treat mesothelioma mesothelioma, a form of cancer that originates from exposure to asbestos. The researchers have tested the vaccine on 10 patients who had been diagnosed with mesothelioma, with all of them showed increased levels of antibodies against the disease and three of them showed that the tumor had decreased in size.
What are symptoms of mesothelioma cancer?
The study, published in the American Journal of Respiratory and Critical Care Medicine, explains bagimana vaccines work by creating cell-dendritic cell antigen in malignant mesothelioma tumors in the lining fluid in the lungs of patients. Dr. Joachim Aerts, the author of the study and lung specialist at the Erasmus Medical Center in Rotterdam, said that approach by using the patient's immune system to attack tumors and is useful for creating immunity to the disease, compared with conventional radiation or chemotherapy treatments.
How histological mesothelioma?
Dr. Aerts said that this is one of a relatively new form of treatment called immunotherapy for cancer. Mesothelioma vaccine can be used and relatively safe, with few side effects when compared with current treatment methods. He expressed the hope that further study could improve the survival rate of patients with the disease mesothelioma. Currently, patients diagnosed with mesothelioma, the prognosis of his life just lived less than two years.
Patients who have been exposed to asbestos typically do not show symptoms of mesothelioma for several years or even decades, after the initial exposure period. At that time, mesothelioma will continue to run metastases in the lungs and seeps into other organs. The other side of this study is that the vaccine could be a direct treatment for workers exposed to asbestos.
Although the side effects shown by the patients in this study are not as severe as that experienced by patients undergoing chemotherapy or radiation treatments, one of the potential effects from a change from the patient's immune system during immunotherapy. The study noted that patients recover quickly and showed no signs of autoimmune disease related.
The distinction between pleural mesothelioma and peritoneal mesothelioma
Dr. Aerts noted a potential problem exists on immunosuppressive disorders. He said that a major problem for treatment of mesothelioma is a tumor to create an environment in the pleural mesothelium which can reduce the effects of the vaccine. He mentioned that the next step in vaccine development is how to provide immunosuppressive around the cancer to improve treatment effectiveness.
Dr. Aerts and her fellow researchers have done some tests on the effects on dendritic cells and how they may affect cancer tumors in mice. Previous research indicates that vaccination produces antibodies needed to destroy malignant cells and maintaining the surrounding healthy tissue to produce a specific immunity.
No comments:
Post a Comment